-controlling interests 8,638 138,189 221,867 48,311 Profit (loss) to owners of parent (578,525) (1,179,473) (2,156,485) (354,355) 2017 % 1 Jan - 30 Sep 2018 (9 mths) %Consolidated statement of income 2015 % 2016
value according to the financial statements as at 31 December 2019 of MV. Summary of financial statement of Medical Vision Company Limited as of 31 December 2019 Item Value (Baht) Total Assets
warning statement suitable for each type of clients. In case the client refused to give personal information or the information are substantially insufficient or not current, or there is reasonably
Statement 19 Table 8 Debt Profile 20 Table 9 Joint Ventures Performance 20 Table 10 IVL Consolidated Statement of Income 21 Table 11 IVL Consolidated Statement of Financial Position 22 Table 12 2019 Planned
price and the market price and plus with the number of offer for sale shares as the expense in the profit and loss statement and record the premium on shares from the Share-based Payment rule in the
Shareholder No.1/2019 Agenda 2 To acknowledge the report on the Company’s operating result for the year 2019 Agenda 3 To acknowledge interim payment Agenda 4 To consider and approve the financial statement of
the consolidated financial statement of the Company for the nine-month period ended 30 September 2019, audited by the certified auditors of the Company, the details in relation to the calculation are as
equivalent to 58.5 percent of the net tangible assets (NTA) of the Company as appeared in the audited consolidated financial statement of the Company ending June 30, 2020, and after computing of the foregoing